Alzheimer’s disease is another neurodegenerative condition for which cannabis (cannabinoid therapy) should work well in the treatment of its symptoms and the disease itself!
In 2004, researchers found that cannabidiol (CBD) inhibits the release of the toxic beta-amyloidal peptide. This peptide is found in the Alzheimer’s brain.
THC reduces the agitation common in Alzheimer’s sufferers. Agitation is the most common behavior problem in patients with this disease (affecting 75%).
Research done by the Scripps Research Institute in California shows that the active ingredient in marijuana, THC, prevents the formation of deposits in the brain associated with Alzheimer's disease. THC was found to prevent an enzyme called acetylcholinesterase from accelerating the formation of "Alzheimer plaques" in the brain more effectively than commercially marketed drugs. THC is also more effective at blocking clumps of protein that can inhibit memory and cognition in Alzheimer’s patients, as reported in Molecular Pharmaceutics
